Report Categories
View AllRecent Articles
View All
Sidus Space SIDU Relative Performance Q3 2023 Profit Disappoints
Redwood RWTN Top Loser Redwood Trust 9125 2029 Notes Post 89 EPS Beat
AMH American Homes 4 Rent Common Shares of Beneficial Interest posts 815 percent Q4 2025 EPS beat shares rise 244 percent
Target Corporation TGT RBC Raises Price Target to 132 as Turnaround Narrative Gains Traction
What separates Saratoga SAT from the pack Ticks Higher 20260503
The key driver behind Regions RFE revenue growth
Wells Fargo Co WFC Initiates Equal Weight Coverage on Check Point Software CHKP Amid Broad Cybersecurity Sector Valuation Adjustments
FDS FactSet delivers narrow Q1 2026 EPS beat shares rise 12 percent on positive investor sentiment
Assurant AIZ Q1 2026 Earnings EPS 595 Beats Estimates
AA Mission YCY Holds 1013 Direction Awaited 20260518
Vanguard Updates US Economic Outlook Modest Growth and Persistent Inflation Risks Ahead
Instil Bio TIL Q4 2025 Beat Revenue NA EPS Exceeds by Significant
Trumps Iron Grip on GOP Signals Political Risk for Financial Markets
ZTO Express Faces Selling Pressure Near Support Zone
Tesla Cybertruck Incident Raises Questions Over Vehicles Water Wading Feature
VOYA Q1 2026 Earnings Strong EPS Beat Amid Steady Performance
Evaluating XLE Energy ETF for Summer Portfolio Positioning
Charter Communications Agrees to Acquire Liberty Broadband at Enhanced Terms
AI Washing UK Companies Scramble to Rebrand as TechFocused Amid AI Hype
Indonesian Commodity Exporters Raise Concerns Over Proposed State Monopoly
Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday
Powell Vows No Shadow Chair Role but Potential Clash with Warsh Looms
OPKO Health Q1 2026 Earnings Narrowly Beats EPS Estimates Amid Operational Focus
LYB Q1 2026 Earnings EPS Surges 140 Above Estimates Amid Improved Operations
Ashland Inc ASH Q1 2026 Earnings Narrow EPS Miss Masks Underlying Resilience Shares Rally
BCAL Q1 2026 Earnings EPS Surprise of 276 Highlights Solid Performance Despite Minor Stock Decline
DRTS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Faces Challenges